577O PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC) — Shahneen Sandhu (2021) | RDL Network
577O PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)
Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Lavinia Spain, Lisa G. Horvath, Megan Crumbaker, A. Antón, Roslyn Wallace, Anupama Pasam, Mathias Bressel, E. Cassidy, Patricia Banks, Nattakorn Dhiantravan, Timothy Akhurst, Aravind Ravi Kumar, Ramin Alipour, Mark Scalzo, Scott Williams, Rodney J. Hicks, Michael S. Hofman
Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Megan Crumbaker, Mathias Bressel, Rhonda Huynh, Patricia Banks, Roslyn Wallace, Anis Hamid, Andrisha Jade Inderjeeth, Ben Tran, Arun Azad, Ramin Alipour, Grace Kong, Aravind Ravi Kumar, Javad Saghebi, Scott Williams, Timothy Akhurst, Rodney J. Hicks, Michael S. Hofman
Justin Ferdinandus, John Violet, Shahneen Sandhu, Rodney J. Hicks, Aravind S. Ravi Kumar, Amir Iravani, Grace Kong, Tim Akhurst, Sue Ping Thang, Declan G. Murphy, Scott Williams, Michael S. Hofman
David L. Goode, Shivakumar Keerthikumar, Santosh Gupta, Anthony M. Joshua, Louise Emmett, Megan Crumbaker, Tori Singer, Ernest W.N. Lam, L. Fernández, E. Jiménez, Dou Zhang, Yvonne G. Lin, Richard Wenstrup, Anupama Pasam, Rodney J. Hicks, Grace Kong, Anis Hamid, Shahneen Sandhu
Anis Hamid, Michael S. Hofman, Mathias Bressel, Louise Emmett, Anthony M. Joshua, Lavinia Spain, Lisa G. Horvath, Megan Crumbaker, Anupama Pasam, Jason Callahan, Alisa Tubbs, Luisa Fernandez, Richard Wenstrup, Grace Kong, Jeremy Lewin, Ben Tran, Arun Azad, Joseph D. Schonhoft, Rodney J. Hicks, Shahneen Sandhu
Discussion(0)
No comments yet. Be the first to comment.